Patient age and donor <scp>HLA</scp> matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups-Reference-Cited by-同舟云学术

Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups

Published:2022-09-10 Issue:6 Volume:109 Page:672-679
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Garcia‐Horton Alejandro¹²^ORCID,Cyriac Sunu L.¹³^ORCID,Gedde‐Dahl Tobias⁴^ORCID,Floisand Yngvar⁵⁶^ORCID,Remberger Mats⁷^ORCID,Mattsson Jonas¹⁸^ORCID,Michelis Fotios V.¹^ORCID

Affiliation:

1. Hans Messner Allogeneic Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network, University of Toronto Toronto Ontario Canada

2. Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences McMaster University Hamilton Ontario Canada

3. Department of Medical Oncology and Hematology Amala Institute of Medical Sciences Thrissur India

4. Stem Cell Transplant Unit, Department of Hematology Oslo University Hospital, Institute of Clinical Medicine, University of Oslo Oslo Norway

5. Stem Cell Transplantation and Cellular Therapies Programme The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool UK

6. CanCell – Centre of Cancer Cell Reprogramming University of Oslo Oslo Norway

7. Department of Medical Sciences Uppsala University and KFUE, Uppsala University Hospital Uppsala Sweden

8. Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Hans Messner Allogeneic Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network, University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13850

Reference30 articles.

1. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

2. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

3. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

4. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study

5. Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related Donor Transplants

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities;World Journal of Clinical Cases;2023-01-16